SHI YI,LIPARI JOHN M.,PADDEN BRIAN E.,DIAS LLOYD E.,SPENCE JULIE K.
申请号：
CO14150990
公开号：
CO7010829A2
申请日:
2014.07.14
申请国别(地区):
CO
年份:
2014
代理人:
摘要：
A composition comprises a kinase inhibitory compound, e.g., N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N&prime；-(3-fluorophenyl)urea, in a mixture comprising (a) a pharmaceutically acceptable water-soluble polymeric carrier and (b) a pharmaceutically acceptable surfactant. The composition is suitable for dilution with an IV solution for administration to a subject in need thereof for treatment of a cancer.
